A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
Researchers will start moving into the 365,000-square-foot building next week.
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
A cancer-cell quirk could be exploited to develop new drugs that starve tumors.
Drugs encapsulated in new MIT nanoparticles can hitch a ride to tumors on the surface of immune-system cells.
Organizations will collaborate in multiple areas of oncology research and technology development.
New program at MIT’s Koch Institute targets the growing cancer problem in India.
Technology offers a new way to test potential cancer drugs, detect effects of hazardous agents in our environment.
MIT biological engineers devise a way to measure, for the first time, how single cells accumulate mass.
MIT’s Matthew Vander Heiden is part of a new generation of cancer researchers trying to exploit cancer cells’ strange metabolism.
Exploiting the recently discovered mechanism could allow biologists to develop disease treatments by shutting down specific genes.
Tumors can arise from different cell types in the pancreas, depending on the circumstances, according to MIT cancer biologists.
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.